These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16887466)

  • 1. The role of mast cells in osteoporosis.
    Chiappetta N; Gruber B
    Semin Arthritis Rheum; 2006 Aug; 36(1):32-6. PubMed ID: 16887466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation and degranulation occur early during induction of periosteal bone resorption.
    Fouilloux I; Duplan MB; Baroukh B; Cherruau M; Saffar JL; Lesclous P
    Bone; 2006 Jan; 38(1):59-66. PubMed ID: 16249129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mast cells in bone pathology].
    Bojoly C; Bouvier M; Bonvoisin B; Lejeune E
    Nouv Presse Med; 1982 Sep; 11(36):2703-6. PubMed ID: 7145658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell-tumor cell interactions: for or against tumour growth and metastasis?
    Dimitriadou V; Koutsilieris M
    Anticancer Res; 1997; 17(3A):1541-9. PubMed ID: 9179193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of mastocytes in 1298 bone biopsies. Relationship between mastocytes and osteoporosis].
    Grardel B; Flautre B; Sutter B; Duriez J; Hardouin P
    Rev Rhum Mal Osteoartic; 1991 Nov; 58(11):759-61. PubMed ID: 1780650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of biochemical markers of bone turnover in osteoporosis.
    Allende-Vigo MZ
    P R Health Sci J; 2007 Jun; 26(2):91-5. PubMed ID: 17722420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mastocyte osteoporosis].
    Camus JP; Prier A; Lièvre JA; Stephan JC; Laveant C
    Rev Rhum Mal Osteoartic; 1979 Jan; 46(1):29-35. PubMed ID: 441665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid.
    Vaes BL; Lute C; Blom HJ; Bravenboer N; de Vries TJ; Everts V; Dhonukshe-Rutten RA; Müller M; de Groot LC; Steegenga WT
    Calcif Tissue Int; 2009 May; 84(5):413-22. PubMed ID: 19363664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mast cell enigma: a personal reflection of what remains to be done.
    Henz BM
    Exp Dermatol; 2008 Feb; 17(2):91-9. PubMed ID: 18205712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
    Nicolin V; Bareggi R; Baldini G; Bortul R; Martinelli B; Narducci P
    Acta Histochem; 2007; 109(5):397-402. PubMed ID: 17574655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
    Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
    Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N; Pierroz DD; Ferrari SL
    J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cells Are Critical Regulators of Bone Fracture-Induced Inflammation and Osteoclast Formation and Activity.
    Kroner J; Kovtun A; Kemmler J; Messmann JJ; Strauss G; Seitz S; Schinke T; Amling M; Kotrba J; Froebel J; Dudeck J; Dudeck A; Ignatius A
    J Bone Miner Res; 2017 Dec; 32(12):2431-2444. PubMed ID: 28777474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging therapies for osteoporosis.
    Mitchner NA; Harris ST
    J Fam Pract; 2009 Jul; 58(7 Suppl Osteoporosis):S45-9. PubMed ID: 19825319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical insights from the etiopathology of osteoporosis.
    Piper BA; Galsworthy TD; Bockman RS
    Contemp Intern Med; 1995 May; 7(5):58-68. PubMed ID: 10150350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of osteoporosis in spinal cord injury.
    Jiang SD; Jiang LS; Dai LY
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):555-65. PubMed ID: 17054455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.